KalVista Pharmaceuticals (KALV)
(Delayed Data from NSDQ)
$10.00 USD
+0.54 (5.71%)
Updated Sep 26, 2024 03:59 PM ET
After-Market: $10.03 +0.03 (0.30%) 6:24 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
KalVista Pharmaceuticals, Inc. (KALV) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$29.20 | $39.00 | $20.00 | 208.67% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for KalVista Pharmaceuticals, Inc. comes to $29.20. The forecasts range from a low of $20.00 to a high of $39.00. The average price target represents an increase of 208.67% from the last closing price of $9.46.
Analyst Price Targets (5 )
Broker Rating
KalVista Pharmaceuticals, Inc. currently has an average brokerage recommendation (ABR) of 1.17 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 1.17 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, five are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 83.33% and 16.67% of all recommendations. A month ago, Strong Buy made up 83.33%, while Buy represented 16.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.17 | 1.17 | 1.17 | 1.17 | 1.17 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/9/2024 | Cantor Fitzgerald & Co | Pete Stavropoulos | Strong Buy | Strong Buy |
7/15/2024 | H.C. Wainwright & Co. | Andrew S Fein | Strong Buy | Strong Buy |
7/12/2024 | Needham & Company | Serge Belanger | Moderate Buy | Moderate Buy |
7/11/2024 | SVB Securities | Joseph P Schwartz | Strong Buy | Strong Buy |
5/17/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.17 |
ABR (Last week) | 1.17 |
# of Recs in ABR | 6 |
Average Target Price | $29.20 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 89 of 253 |
Current Quarter EPS Est: | -0.95 |
KALV FAQs
KalVista Pharmaceuticals, Inc. (KALV) currently has an average brokerage recommendation (ABR) of 1.17 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 6 brokerage firms.
The average price target for KalVista Pharmaceuticals, Inc. (KALV) is $29.20. The current on short-term price targets is based on 5 reports.
The forecasts for KalVista Pharmaceuticals, Inc. (KALV) range from a low of $20 to a high of $39. The average price target represents a increase of $208.67 from the last closing price of $9.46.
The current UPSIDE for KalVista Pharmaceuticals, Inc. (KALV) is 208.67%
Based on short-term price targets offered by five analysts, the average price target for KalVista Pharmaceuticals, Inc. comes to $29.20. The forecasts range from a low of $20.00 to a high of $39.00. The average price target represents an increase of 208.67% from the last closing price of $9.46.